Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)
NCT ID: NCT02842723
Last Updated: 2024-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
33 participants
INTERVENTIONAL
2010-03-31
2021-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Study of Children and Adolescents With Craniopharyngioma
NCT01272622
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
NCT02792582
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
NCT00258453
Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma
NCT00005084
Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers
NCT02802969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Protontherapy
Protontherapy
59,5 Gy (1,7 Gy daily, 5 fractions per week).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protontherapy
59,5 Gy (1,7 Gy daily, 5 fractions per week).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age range between 3 and 16 years
* Landsky performance status \> 60
* Incomplete surgical resection or simple biopsy
* Solid and/or cystic aspect on imaging
* Irradiation performed at the time of presentation or of local progression
* Signed informed consent by parents or by legal representative (with copy to each participating center)
Exclusion Criteria
* Severe vasculopathy
* Participation to a concurrent study
* Contra-indication to general anesthesia in children below 5 years
* Patient non-compliant to a minimum 30 mn immobilisation
* Patient deprived of freedom or under guardianship
* Patient not expected to be followed in a long run
3 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Curie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Curie
Paris, , France
Groupe Hospitalier Necker Enfants Malades
Paris, , France
Gustave Roussy
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IC 2008-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.